William S Hendley

Poliovirus Immunity among Children Aged 6–11 and 36–48 Months in 14 Polio High-Risk Provinces of Afghanistan: A Health-Facility-Based Study

Noha H Farag, S. Soofi, W. Weldon, 2022, Vaccines.

Inactivated Poliovirus Vaccine Closing the Type 2 Immunity Gap in Vietnam

Bernardo A. Mainou, D. Anh, V. Jeyaseelan, 2022, Journal of the Pediatric Infectious Diseases Society.

Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trial

M. Yunus, J. Clemens, Bernardo A. Mainou, 2022, The Lancet.

Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trial

M. Yunus, J. Clemens, Bernardo A. Mainou, 2022, The Lancet.

Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission—Niger Experience

Bernardo A. Mainou, A. Goel, O. Mach, 2021, Open forum infectious diseases.